Cargando…

Predicting left ventricular functional recovery in ischaemic cardiomyopathy: needs and challenges

Left ventricular (LV) systolic function is an essential parameter for the evaluation of patients with ischaemic heart disease, and therapeutic choices are significantly driven by LV ejection fraction (LVEF) in the early stage of the disease and during follow-up. After an acute coronary syndrome, ven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radesich, Cinzia, Cappelletto, Chiara, Indennidate, Carla, Perotto, Maria, Di Lenarda, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	CCC 2023 - State of the Art Cardiology Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120944/ https://www.ncbi.nlm.nih.gov/pubmed/37091642 http://dx.doi.org/10.1093/eurheartjsupp/suad071

Ejemplares similares

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Sudden cardiac death in ischaemic heart disease: coronary thrombosis or myocardial fibrosis?
por: Prati, Francesco, et al.
Publicado: (2023)

Cardiology of the future: xenotransplantation with porcine heart
por: Sinagra, Gianfranco, et al.
Publicado: (2022)

Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023)

Ablation of ventricular arrhythmias in cardiogenetic diseases
por: Pappone, Carlo, et al.
Publicado: (2023)

Indications, evidence, and controversy in the closure of the left atrial appendage
por: Patti, Giuseppe, et al.
Publicado: (2023)

DOACs and rheumatic valvulopathy: always a red light?
por: Rochira, Carla, et al.
Publicado: (2023)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Nightmare in the ward: difficult Clostridioides infection
por: Tarasi, Agapito
Publicado: (2023)

Takotsubo syndrome: more frequent in women, more dangerous in men
por: Natale, Enrico, et al.
Publicado: (2023)

Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023)

What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?
por: Vassiliki’ Cousoumbas, Gloria, et al.
Publicado: (2023)

The temptation of anticoagulant therapy after transcatheter aortic valve implantation
por: Gatto, Laura, et al.
Publicado: (2023)

Atrial fibrillation in heart failure: drugs or ablation?
por: Palmas, Francesco, et al.
Publicado: (2023)

Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?
por: Bisceglia, Irma, et al.
Publicado: (2023)

Sudden death in ischemic heart disease: looking for new predictors: polygenic risk
por: Boccanelli, Alessandro, et al.
Publicado: (2023)

Treatment of amyloidosis: present and future
por: Mallus, Maria Teresa, et al.
Publicado: (2023)

The metaverse in medicine
por: Massetti, Massimo, et al.
Publicado: (2023)

How much does the presentation pattern of atrial fibrillation affect thrombo-embolic risk and mortality?
por: Turturiello, Dario, et al.
Publicado: (2023)

Treatment of multiple valve disease: surgery, structural intervention, or both?
por: Berti, Sergio, et al.
Publicado: (2023)

Treating chronic kidney disease to reduce cardiovascular risk
por: Cice, Gennaro, et al.
Publicado: (2023)

The new in anticoagulation: factor XI inhibitors
por: Muscente, Francesca, et al.
Publicado: (2023)

In search of new gatekeepers: coronary CT (Computed Tomography) in acute coronary syndrome
por: Schillaci, Matteo, et al.
Publicado: (2023)

Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act
por: Musumeci, Giuseppe, et al.
Publicado: (2023)

Causes of sudden death
por: De Gaspari, Monica, et al.
Publicado: (2023)

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
por: Ferri, Nicola, et al.
Publicado: (2023)

Heart failure therapy: the fifth card
por: Balestrieri, Giulio, et al.
Publicado: (2023)

Long-term follow-up after invasive or conservative management of stable coronary disease: the ISCHEMIA-EXTEND study
por: Bolognese, Leonardo, et al.
Publicado: (2023)

A focus on the percutaneous therapy of mitral and tricuspid regurgitation
por: Frazzetto, Marco, et al.
Publicado: (2023)

Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis
por: Pepi, Mauro, et al.
Publicado: (2023)

Renal denervation and long-term results
por: Simonetti, Fiorenzo, et al.
Publicado: (2023)

Spontaneous coronary artery dissection: an unpredictable event
por: Smirnova, Alexandra, et al.
Publicado: (2023)

Less sodium and more potassium to reduce cardiovascular risk
por: Muiesan, Maria Lorenza, et al.
Publicado: (2023)

Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease
por: Palazzini, Massimiliano, et al.
Publicado: (2023)

Therapy of Type 2 diabetes: more gliflozines and less metformin?
por: Verdecchia, Paolo, et al.
Publicado: (2023)

Impact of the exposome on cardiovascular disease
por: Bonanni, Alice, et al.
Publicado: (2023)

Clinical results and mechanism of action of icosapent ethyl
por: Borghi, Claudio, et al.
Publicado: (2023)

Dilemmas in cardiology: when to recanalize a chronic total occlusion
por: Stazi, Filippo
Publicado: (2023)

How much does hypertension in pregnancy affect the risk of future cardiovascular events?
por: Mureddu, Gian Francesco
Publicado: (2023)

Cardiovascular prevention: Mediterranean or low-fat diet?
por: Temporelli, Pier Luigi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_61shoretkg5nthbdhbd9qo94rc